89bio, Inc. (ETNB)

USD 7.61

(-4.64%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 273 Thousand 240 Thousand 79 Thousand 60 Thousand 17 Thousand 6000.00
Gross Profit -273 Thousand -240 Thousand -79 Thousand -60 Thousand -17 Thousand -6000.00
Operating Expenses 151.2 Million 102.24 Million 89.74 Million 49.35 Million 26.64 Million 15.16 Million
Selling, General and Administrative Expenses 28.97 Million 21.45 Million 19.41 Million 13.15 Million 5.29 Million 1.48 Million
Research and Development Expenses 122.23 Million 80.79 Million 70.33 Million 36.19 Million 21.34 Million 13.68 Million
Other Expenses - 242 Thousand -526 Thousand -203 Thousand -30.56 Million -986 Thousand
Cost and Expenses 151.2 Million 102.24 Million 89.74 Million 49.35 Million 26.64 Million 15.16 Million
Operating Income -151.2 Million 102.24 Million -89.74 Million -49.35 Million -26.64 Million -15.16 Million
Interest Expense 3.58 Million 1.92 Million 674 Thousand - - -
Income Tax Expense 3.86 Million 19 Thousand -147 Thousand -59 Thousand 218 Thousand 28 Thousand
Earnings before Tax -138.32 Million -102 Million -90.26 Million -49.55 Million -57.2 Million -16.14 Million
Net Income -142.18 Million -102.02 Million -90.12 Million -49.49 Million -57.42 Million -16.17 Million
Earnings Per Share Basic -2.00 -2.93 -4.48 -3.08 -5.40 -3.53
Earnings Per Share Diluted -2.00 -2.93 -4.48 -3.08 -5.40 -3.53
Weighted Average Shares Outstanding 71.17 Million 34.8 Million 20.09 Million 16.08 Million 10.63 Million 4.58 Million
Weighted Average Shares Outstanding (Diluted) 71.17 Million 34.8 Million 20.09 Million 16.08 Million 10.63 Million 4.58 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -134.46 Million -99.84 Million -90.19 Million -49.49 Million -57.18 Million -16.14 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts